Literature DB >> 10378179

Importance of the vestibular system in visually induced nausea and self-vection.

W H Johnson1, F A Sunahara, J P Landolt.   

Abstract

The objective of this study was to determine the importance, if any, of the non-auditory labyrinth of the inner ear in visually induced nausea and self-vection in subjects exposed to a moving visual field with and without concomitant pitching head movements. Subjects treated were 15 normals, 18 unilateral labyrinthectomies and 6 bilateral labyrinthectomies. The findings show a higher incidence of pseudo-Coriolis induced nausea in normal subjects compared to unilateral and bilateral labyrinthectomized subjects. When the subjects were exposed to the moving visual field only (no head movement), pronounced self-vection occurred in all subjects, but with earlier onset in the bilateral labyrinthine defective subjects as compared to normal and unilateral defective subjects. The subjective intensities of self-vections reported by labyrinth-defectives were much more pronounced as compared to normal subjects, and it is apparent that visual input in these subjects achieves much more importance in maintaining compensatory eye movements, and the gain of neck reflexes is enhanced. The findings that visual stimulation is more effective in producing the disabling effects after labyrinthine destruction could possibly be explained by enhancement of vision after loss of labyrinthine sensory input, and the gain in neck reflexes is also enhanced after labyrinthectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10378179

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  18 in total

1.  Motion sickness induced by off-vertical axis rotation (OVAR).

Authors:  Mingjia Dai; Sofronis Sofroniou; Mikhail Kunin; Theodore Raphan; Bernard Cohen
Journal:  Exp Brain Res       Date:  2010-06-10       Impact factor: 1.972

2.  Labyrinthine lesions and motion sickness susceptibility.

Authors:  Mingjia Dai; Theodore Raphan; Bernard Cohen
Journal:  Exp Brain Res       Date:  2007-01-26       Impact factor: 1.972

Review 3.  Space motion sickness.

Authors:  James R Lackner; Paul Dizio
Journal:  Exp Brain Res       Date:  2006-10-05       Impact factor: 1.972

4.  Prolonged reduction of motion sickness sensitivity by visual-vestibular interaction.

Authors:  Mingjia Dai; Ted Raphan; Bernard Cohen
Journal:  Exp Brain Res       Date:  2011-02-02       Impact factor: 1.972

Review 5.  Mal de debarquement.

Authors:  Yoon-Hee Cha
Journal:  Semin Neurol       Date:  2009-10-15       Impact factor: 3.420

6.  Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

Authors:  D Bolognini; E M Rock; N L Cluny; M G Cascio; C L Limebeer; M Duncan; C G Stott; F A Javid; L A Parker; R G Pertwee
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 7.  Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sickness.

Authors:  Bill J Yates; Michael F Catanzaro; Daniel J Miller; Andrew A McCall
Journal:  Exp Brain Res       Date:  2014-04-16       Impact factor: 1.972

8.  Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness.

Authors:  Seong-Hae Jeong; Sun-Young Oh; Hyo-Jung Kim; Ja-Won Koo; Ji Soo Kim
Journal:  J Neurol       Date:  2009-12-30       Impact factor: 4.849

9.  Motion sickness diagnostic criteria: Consensus Document of the Classification Committee of the Bárány Society.

Authors:  Yoon-Hee Cha; John F Golding; Behrang Keshavarz; Joseph Furman; Ji-Soo Kim; Jose A Lopez-Escamez; Måns Magnusson; Bill J Yates; Ben D Lawson
Journal:  J Vestib Res       Date:  2021       Impact factor: 2.354

10.  Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility.

Authors:  Jun-Qin Wang; Rui-Rui Qi; Wei Zhou; Yi-Fan Tang; Lei-Lei Pan; Yi-Ling Cai
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.